The present invention concerns combinations of a pyrimidine containing NNRTInamed TMC278 with nucleoside reverse transcriptase inhibitors such asemtricitabine, lamivudine or abacavir and/or nucleotide reverse transcriptaseinhibitors such as tenofovir useful for the treatment of HIV infected patientsor for the prevention of HIV transmission or infection.